03 April 2012 12:20 [Source: ICIS news]
LONDON (ICIS)--UBS has raised French specialty chemical firm Arkema’s share price target from €57 to €76, because the company is expected to benefit from better business conditions in 2012, the investment bank said on Tuesday.
UBS said Arkema expects around €75m ($100m) of incremental earnings before interest, tax, depreciation and amortisation (EBITDA) from acquisitions and capacity expansion.
“We think that after the vinyls divestment [announced in November 2011], perceived earnings volatility has significantly reduced, which should trigger multiple re-rating in the medium term,” the bank added.
The bank added that it sees Arkema’s long-term targets as realistic, particularly because the company is already showing signs of resilience in its earnings in 2012.
UBS has maintained its “neutral” rating for Arkema.
($1 = €0.75)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections